- Home
- JDZG vs MURA Comparison
JDZG vs MURA Comparison
Compare JDZG & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- MURA
- Stock Information
- Founded
- JDZG 2020
- MURA 2013
- Country
- JDZG China
- MURA Ireland
- Employees
- JDZG N/A
- MURA N/A
- Industry
- JDZG Other Consumer Services
- MURA
- Sector
- JDZG Real Estate
- MURA
- Exchange
- JDZG Nasdaq
- MURA Nasdaq
- Market Cap
- JDZG 18.4M
- MURA 17.7M
- IPO Year
- JDZG 2024
- MURA N/A
- Fundamental
- Price
- JDZG $0.53
- MURA $2.63
- Analyst Decision
- JDZG
- MURA Strong Buy
- Analyst Count
- JDZG 0
- MURA 4
- Target Price
- JDZG N/A
- MURA $13.00
- AVG Volume (30 Days)
- JDZG 530.0K
- MURA 14.0M
- Earning Date
- JDZG 05-20-2025
- MURA 05-20-2025
- Dividend Yield
- JDZG N/A
- MURA N/A
- EPS Growth
- JDZG N/A
- MURA N/A
- EPS
- JDZG 0.03
- MURA N/A
- Revenue
- JDZG $2,567,741.00
- MURA N/A
- Revenue This Year
- JDZG N/A
- MURA $34.35
- Revenue Next Year
- JDZG N/A
- MURA N/A
- P/E Ratio
- JDZG $17.04
- MURA N/A
- Revenue Growth
- JDZG 20.36
- MURA N/A
- 52 Week Low
- JDZG $0.45
- MURA $0.95
- 52 Week High
- JDZG $15.08
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- MURA 56.94
- Support Level
- JDZG N/A
- MURA $2.48
- Resistance Level
- JDZG N/A
- MURA $2.66
- Average True Range (ATR)
- JDZG 0.00
- MURA 0.12
- MACD
- JDZG 0.00
- MURA 0.04
- Stochastic Oscillator
- JDZG 0.00
- MURA 42.58
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.